Ignite Creation Date:
2025-12-24 @ 9:25 PM
Ignite Modification Date:
2026-02-01 @ 2:36 PM
Study NCT ID:
NCT07020832
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-06-13
First Post:
2025-06-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 3 Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft Transplantation
Sponsor:
Apellis Pharmaceuticals, Inc.
Organization: